BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10461359)

  • 1. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.
    Solcia E; Rindi G; Paolotti D; Luinetti O; Klersy C; Zangrandi A; La Rosa S; Capella C
    Yale J Biol Med; 1998; 71(3-4):285-90. PubMed ID: 10461359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic aspects of gastric neuroendocrine tumors.
    Rindi G
    Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of ECL-cell abnormalities.
    Hirschowitz BI
    Yale J Biol Med; 1998; 71(3-4):303-10. PubMed ID: 10461361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoid tumors of the stomach in atrophic autoimmune gastritis: classification, differential diagnosis and prognosis].
    Rappel S; Rindi G; Bordi C; Capella C; Solcia E; Altendorf-Hofmann A; Stolte M
    Verh Dtsch Ges Pathol; 1996; 80():199-207. PubMed ID: 9065002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of ECL cell tumors.
    Cadiot G; Cattan D; Mignon M
    Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
    Solcia E; Rindi G; Larosa S; Capella C
    Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
    Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple gastric carcinoids and endocrine cell micronests in type A gastritis: Nuclear morphometric and immunohistochemical analysis.
    Iwai K; Yao T; Nakamura S; Matsumoto T; Nishiyama K; Iida M; Tsuneyoshi M
    Oncol Rep; 2005 Mar; 13(3):397-404. PubMed ID: 15706407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
    Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
    Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A: is it a useful marker of neuroendocrine tumors?
    Campana D; Nori F; Piscitelli L; Morselli-Labate AM; Pezzilli R; Corinaldesi R; Tomassetti P
    J Clin Oncol; 2007 May; 25(15):1967-73. PubMed ID: 17513802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastric neuroendocrine tumor].
    Díaz-Sánchez CL; Molano Romero RA; Martínez González M; Márquez Rivera ML; Halabe-Cherem J
    Rev Gastroenterol Mex; 1998; 63(2):97-100. PubMed ID: 10068736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of ECL cell tumors in humans.
    Bordi C; D'Adda T; Azzoni C; Ferraro G
    Yale J Biol Med; 1998; 71(3-4):273-84. PubMed ID: 10461358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis.
    Solcia E; Fiocca R; Villani L; Luinetti O; Capella C
    Am J Surg Pathol; 1995; 19 Suppl 1():S1-7. PubMed ID: 7762735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
    Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
    Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric carcinoids.
    Bordi C
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S94-7. PubMed ID: 10604110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in human gastric carcinoma.
    Waldum HL; Aase S; Kvetnoi I; Brenna E; Sandvik AK; Syversen U; Johnsen G; Vatten L; Polak JM
    Cancer; 1998 Aug; 83(3):435-44. PubMed ID: 9690535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.